|
1
|
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
|
Circulation
|
2003
|
3.45
|
|
2
|
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans.
|
Clin Pharmacol Ther
|
2002
|
1.63
|
|
3
|
Quality improvement in the door-to-balloon times for ST-elevation myocardial infarction patients presenting without chest pain.
|
Catheter Cardiovasc Interv
|
2011
|
1.46
|
|
4
|
Proximal landing zone extension for TEVAR.
|
J Invasive Cardiol
|
2011
|
1.38
|
|
5
|
In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
|
JACC Cardiovasc Interv
|
2009
|
1.24
|
|
6
|
Plaque development, vessel curvature, and wall shear stress in coronary arteries assessed by X-ray angiography and intravascular ultrasound.
|
Med Image Anal
|
2006
|
1.04
|
|
7
|
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
|
Am Heart J
|
2008
|
0.95
|
|
8
|
Real-time three-dimensional transesophageal echocardiography of the left atrial appendage: initial experience in the clinical setting.
|
J Am Soc Echocardiogr
|
2008
|
0.94
|
|
9
|
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients.
|
Am J Cardiol
|
2003
|
0.93
|
|
10
|
Effects of vessel geometry and catheter position on dose delivery in intracoronary brachytherapy.
|
IEEE Trans Biomed Eng
|
2003
|
0.88
|
|
11
|
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry).
|
Am J Cardiol
|
2012
|
0.88
|
|
12
|
Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry.
|
Circulation
|
2011
|
0.83
|
|
13
|
Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
|
Am Heart J
|
2013
|
0.75
|
|
14
|
Platelet resistance - much known and much more unknown.
|
J Invasive Cardiol
|
2011
|
0.75
|
|
15
|
Drug-eluting stents for critical limb ischemia.
|
J Am Coll Cardiol
|
2010
|
0.75
|
|
16
|
Percutaneous life support: is it safe to plug and play?
|
J Invasive Cardiol
|
2011
|
0.75
|
|
17
|
Subclavian steal syndrome successfully treated with a novel application of embolic capture angioplasty.
|
Int J Angiol
|
2012
|
0.75
|
|
18
|
Predicting Locations of High-Risk Plaques in Coronary Arteries in Patients Receiving Statin Therapy.
|
IEEE Trans Med Imaging
|
2017
|
0.75
|
|
19
|
Changing illness perceptions and adherence to dual antiplatelet therapy in patients with stable coronary disease.
|
J Cardiovasc Nurs
|
2013
|
0.75
|
|
20
|
Spontaneous Coronary Artery Dissection in Loeys-Dietz Syndrome: Role of Optical Coherence Tomography in Diagnosis and Management.
|
J Invasive Cardiol
|
2015
|
0.75
|